I believe I can provide some insight into that one.
There are investors who are of the opinion GLP1's are the death of CPAP, but I don't believe they are in the majority.
We have also witnessed an extraordinary amount of shorting. I can only speculate if they are current holders covering these positions until the next quarterly, Hedge funds, or Long/Short managers. You don't necessarily need a lot of sticky hands selling to get the share price move we have seen.
Take a look at Facebook and Netflix over the last 12 months for example.
Ann: ResMed Announces Results for the Fourth Quarter of FY2023, page-281
-
- There are more pages in this discussion • 91 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$28.52 |
Change
0.090(0.32%) |
Mkt cap ! $18.07B | |||
| Open | High | Low | Value | Volume |
| $28.40 | $28.62 | $28.31 | $26.21M | 919.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1694 | $28.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $28.53 | 55 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| RMD (ASX) Chart |